Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and ...

After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus. In two new studies, ...

“It is a pathogen in dire need of control because it causes significant morbidity and mortality not just in the United States ...

We are very pleased with our collaboration with Innoviva Specialty Therapeutics for the commercialization of Zevtera in the US. The company is a highly committed, focused and capable partner that ...

Basilea enters agreement with Innoviva Specialty Therapeutics for commercialization of antibiotic Zevtera in US: Allschwil, Switzerland Tuesday, December 17, 2024, 15:00 Hrs [IST] ...

Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the ...

Innoviva, Inc. (INVA) announced Monday that its unit Innoviva Specialty Therapeutics, Inc. or IST has entered into an exclusive ...

Fonseca Biosciences ("Fonseca") announced today an agreement with MerLion Pharmaceuticals GmbH granting Fonseca the exclusive ...